[Main ingredients] tylosin phosphate
[Pharmacological action] Pharmacodynamics Tylosin is a macrolide antibiotic, which inhibits bacterial protein synthesis by blocking peptide transfer and mRNA displacement through reversible binding with 50S subunit of bacterial ribosome. This effect is basically limited to rapidly dividing bacteria and mycoplasmas, belonging to the growth period of fast acting bacteriostatic agents. This product is mainly effective against gram-positive bacteria and mycoplasma, with weak effect on bacteria and strong effect on mycoplasma. Sensitive gram-positive bacteria include Staphylococcus aureus (including penicillin resistant Staphylococcus aureus), pneumococcus, streptococcus, Bacillus anthracis, Listeria, Clostridium putrescence, Clostridium emphysema, etc. Sensitive bacteria can be resistant to tylosin, and Staphylococcus aureus has some cross resistance to tylosin and erythromycin.